(Total Views: 471)
Posted On: 06/27/2024 12:42:21 PM
Post# of 154248
Madrigal has been the darling of NASH since December of 2022 when it soared 267% in value to $267.00 a share... with 30% of patients responding to cessation of scarring and progression of symptoms.
56% of patients hit ONE of the goals in Madrigal study.
This company came out of the gate at almost $ $350. a share at inception. TODAY has a MKT Cap of over $6 Billion...and we're going to bed....love the sleep-overs.
56% of patients hit ONE of the goals in Madrigal study.
This company came out of the gate at almost $ $350. a share at inception. TODAY has a MKT Cap of over $6 Billion...and we're going to bed....love the sleep-overs.
(9)
(0)
